Qiagen N.V.

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample mater…

Medical - Diagnostics & Research

NL, Venlo [HQ]

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about Qiagen N.V.'s gradings, price targets and earnings estimates.

Earnings

See the historical earnings and what wall street analysts forecasted and
forecast for future earnings.

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.
FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2014	0.3100	1.120	1,301	1,403	69	120	103	370	63	164	570	526
2015	0.5200	1.143	1,344	1,284	116	128	194	365	160	177	503	467
2016	0.5700	1.149	1,280	1,343	127	76	361	293	175	94	464	498
2017	0.3600	1.287	1,337	1,415	80	40	308	365	98	148	530	550
2018	0.1800	1.370	1,417	1,509	40	182	380	478	153	256	575	510
2019	0.8400	1.433	1,501	1,521	190	-42	499	215	266	-29	533	499
2020	-0.1900	2.173	1,526	1,848	-41	328	567	647	313	345	504	466
2021	0.3300	2.582	1,870	2,196	73	461	764	806	544	249	544	526
2022	2.3200	2.373	2,251	2,134	512	468	923	808	657	582	584	544
2023	1.9200	2.102	2,141	1,959	423	72	824	915	576	659	603	620
2024	1.5400	2.146	1,965	1,974	341	480	650	752	445	532	579	575
2025	-	2.286	-	2,085	-	511	-	795	-	562	-	607
2026	-	2.517	-	2,228	-	2.F12X/td>	-	2.F121/td>	-	2.F121	-	2.F121
2027	-	2.729	-	2,381	-	1.F13X/td>	-	1.F131/td>	-	1.F131	-	1.F131
2028	-	2.990	-	2,538	-	0.F14X/td>	-	0.F141/td>	-	0.F141	-	0.F141

Institutional Sentiment

Wall Street · Earnings · Institutional Sentiment

The institutional sentiment measures the direction of new stock gradings
and price targets while comparing them Year-over-Year. We've limited the grading institutes to those we see as top-tier and update this data every month.

Morgan Stanley

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

JP Morgan Chase

1Y Ago:

Overweight

Prev. Grade

Overweight

Nov. 6, 2024

Overweight

Citigroup

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Overall Consensus

Here we aggregate the price targets and gradings of all IBs/AMCs/Brokerage firms inside our database to draw a bigger picture.

Grading Consensus

Click to each, to see the grade

Price Target Consensus

-18.401% $7.78 · MISS

Nov. 6, 2024

Price Then

$43.95

Price Target

$50.06

Price Now

$42.28